The D3 receptor and improvement in positive symptoms of schizophrenia

被引：0
|
作者：
Staddon, S [1 ]
Arranz, MJ [1 ]
Mancama, D [1 ]
Beperet, M [1 ]
Munro, J [1 ]
Osborne, S [1 ]
Collier, D [1 ]
Mata, I [1 ]
Kerwin, R [1 ]
机构：
[1] Inst Psychiat, London SE5 8AF, England
来源：
SCHIZOPHRENIA RESEARCH | 2002年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [11] HOMOZYGOSITY AT THE DOPAMINE D3 RECEPTOR LOCUS IS NOT ASSOCIATED WITH SCHIZOPHRENIA
    LAURENT, C
    SAVOYE, C
    SAMOLYK, D
    MELONI, R
    MALLET, J
    CAMPION, D
    MARTINEZ, M
    DAMATO, T
    BASTARD, C
    DOLLFUS, S
    JOURNAL OF MEDICAL GENETICS, 1994, 31 (03) : 260 - 260
  • [12] RELATIONSHIP BETWEEN HOMOZYGOSITY AT THE DOPAMINE D3 RECEPTOR GENE AND SCHIZOPHRENIA
    MANT, R
    WILLIAMS, J
    ASHERSON, P
    PARFITT, E
    MCGUFFIN, P
    OWEN, MJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 54 (01): : 21 - 26
  • [13] Dopamine D3 receptor and schizophrenia: A widened scope for the immune hypothesis
    Vogel, Matthias
    Busse, Stefan
    Freyberger, Harald J.
    Grabe, Hans Joergen
    MEDICAL HYPOTHESES, 2006, 67 (02) : 354 - 358
  • [14] Dopamine and glutamate dysfunctions in schizophrenia:: Role of the dopamine D3 receptor
    Leriche, L
    Diaz, J
    Sokoloff, P
    NEUROTOXICITY RESEARCH, 2004, 6 (01) : 63 - 71
  • [15] No linkage or association between schizophrenia and the dopamine D3 receptor polymorphism
    Hawi, Z
    Straub, RE
    ONeill, A
    Kendler, KS
    Walsh, D
    Gill, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 625 - 625
  • [16] Dopamine D3 receptor gene variants and substance abuse in schizophrenia
    Krebs, MO
    Sautel, F
    Bourdel, MC
    Sokoloff, P
    Schwartz, JC
    Olie, JP
    Loo, H
    Poirier, MF
    MOLECULAR PSYCHIATRY, 1998, 3 (04) : 337 - 341
  • [17] Dopamine D3 receptor gene variants and substance abuse in schizophrenia
    M-O Krebs
    F Sautel
    M-C Bourdel
    P Sokoloff
    J-C Schwartz
    J-P Olié
    H Lôo
    M-F Poirier
    Molecular Psychiatry, 1998, 3 : 337 - 341
  • [18] Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor
    Ludovic Leriche
    Jorge Diaz
    Pierre Sokoloff
    Neurotoxicity Research, 2004, 6 : 63 - 71
  • [19] Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms
    Laszlovszky, I.
    Barabassy, A.
    Kiss, B.
    Szatmari, B.
    Adham, N.
    Earley, W.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S398 - S399
  • [20] ASSOCIATION STUDIES IN SCHIZOPHRENIA USING A DOPAMINE D3 RECEPTOR GENE POLYMORPHISM
    NIMGAONKAR, VL
    ZHANG, XR
    CALDWELL, JG
    GANGULI, R
    CHAKRAVARTI, A
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 669 - 669
12345